Mission Statement
The Inter-American Drug
Abuse Control Commission (CICAD) was established by the General Assembly
of the Organization of American States (OAS) in 1986 as the Western Hemisphere's
policy forum on all aspects of the drug problem. Each member government
appoints a high-ranking representative to the Commission, which meets
twice a year. CICAD promotes regional cooperation and coordination among
the thirty-four OAS member states through action programs, carried out
by CICADs permanent Secretariat, to:
-
Prevent and treat
substance abuse;
-
Reduce the supply and
availability of illicit drugs;
-
Strengthen national
drug control institutions and machinery;
-
Improve firearms and
money laundering control laws and practice;
-
Develop alternate
sources of income for growers of coca, poppy, and marijuana;
-
Assist member governments to improve their data gathering and analysis on all aspects
of the drug issue, and
-
Help member states and
the hemisphere as a whole measure their progress over time in addressing
the drug problem.
CICAD's core mission is
to enhance the human and institutional capacities of its member states to reduce the production, trafficking and use of illegal drugs, and to address the health, social and criminal consequences of the drug trade. CICAD is the OAS agency that:
-
Serves as the Western Hemisphere's policy forum on all
aspects of the drug problem;
-
Fosters multilateral
cooperation on drug issues in the Americas;
-
Executes action
programs to strengthen the capacity of CICAD member states to prevent
and treat licit and illicit drug abuse;
combat production of illicit drugs, and deny the traffickers their illegal
profits;
-
Promotes drug-related
research, information exchange, specialized training, and technical
assistance; and
-
Develops and recommends minimum standards for drug-related
legislation, treatment, the measurement of both drug consumption and
the cost of drugs to society, and drug-control measures, among
others; and
-
Carries out regular multilateral evaluations of progress by
member states in all aspects of the drug problem (MEM).
|